Aclaris Therapeutics ACRS
NASDAQ ACRS
$4.16 -0.08 (-2.00%)
As of: Nov 10, 2026 · 3:51 PM EST

Aclaris Therapeutics (ACRS) Debt Ratio (2018 - 2021)

Updated

Aclaris Therapeutics' Debt Ratio came in at 0.04 for Q2 2021, down 70.1% from 0.12 a year earlier and down 43.8% from the prior quarter.

Analysis

Aclaris Therapeutics (ACRS) Debt Ratio (2018 - 2021) Analysis & Trends

For FY2020, Aclaris Therapeutics' Debt Ratio was 0.15.

  • Going back by year, Debt Ratio was 0.11 in FY2018.
  • The Q2 2021 figure represents the lowest quarterly Debt Ratio in data going back to Q4 2018.
  • Business Quant data shows ACRS's Debt Ratio at 0.07 (Q1 2021), 0.15 (Q4 2020) and 0.15 (Q3 2020) in the three quarters before Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 0.33
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 0.23
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 0.55
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 0.41
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 0.08
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 0.28
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 0.56
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 0.51
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 0.31
10 Aclaris Therapeutics 638.89 Mn 236.88 Mn 1.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 0.04
Mar 31, 2021 0.07
Dec 31, 2020 0.15
Sep 30, 2020 0.15
Jun 30, 2020 0.12
Mar 31, 2020 0.11
Sep 30, 2019 0.19
Jun 30, 2019 0.14
Mar 31, 2019 0.12
Dec 31, 2018 0.11
API Access

Aclaris Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=ACRS&period=max&api_key=YOUR_API_KEY